AAAAAA

   
Results: 1-17 |
Results: 17
Purification of soluble recombinant human Fc gamma RII (CD32)
Authors: Gruel, N Chapiro, J Fridman, WH Teillaud, JL
Citation: N. Gruel et al., Purification of soluble recombinant human Fc gamma RII (CD32), PREP BIOC B, 31(4), 2001, pp. 341-354
The Fc receptor for IgG expressed in the villus endothelium of human placenta ts Fc gamma RIIb2
Authors: Lyden, TW Robinson, JM Tridandapani, S Teillaud, JL Garber, SA Osborne, JM Frey, J Budde, P Anderson, CL
Citation: Tw. Lyden et al., The Fc receptor for IgG expressed in the villus endothelium of human placenta ts Fc gamma RIIb2, J IMMUNOL, 166(6), 2001, pp. 3882-3889
Differential modulation of stimulatory and inhibitory Fc gamma receptors on human monocytes by Th1 and Th2 cytokines
Authors: Pricop, L Redecha, P Teillaud, JL Frey, J Fridman, WH Sautes-Fridman, C Salmon, JE
Citation: L. Pricop et al., Differential modulation of stimulatory and inhibitory Fc gamma receptors on human monocytes by Th1 and Th2 cytokines, J IMMUNOL, 166(1), 2001, pp. 531-537
Cytokine production and T-cell activation by macrophage-dendritic cells generated for therapeutic use
Authors: Coronel, A Boyer, A Franssen, JD Romet-Lemonne, JL Fridman, WH Teillaud, JL
Citation: A. Coronel et al., Cytokine production and T-cell activation by macrophage-dendritic cells generated for therapeutic use, BR J HAEM, 114(3), 2001, pp. 671-680
A scFv phage display mini library generated from the immunoglobulin repertoire of breast medullary carcinoma infiltrating B lymphocytes
Authors: Kotlan, B Simsa, P Gruel, N Foldi, J Fridman, WH Petranyi, G Teillaud, JL
Citation: B. Kotlan et al., A scFv phage display mini library generated from the immunoglobulin repertoire of breast medullary carcinoma infiltrating B lymphocytes, DIS MARKER, 16(1-2), 2000, pp. 25-27
Immunotargeting of tumors: state of the art and prospects in 2000
Authors: Pelegrin, A Xavier, F Barbet, J Bartholeyns, J Baty, D Buchegger, F Chatal, JF Dubief, F Guerreau, D Gruaz-Guyon, A Lamotte, D Leserman, L Mach, JP Robert, B Saccavini, JC Teillaud, JL Teulon, I
Citation: A. Pelegrin et al., Immunotargeting of tumors: state of the art and prospects in 2000, B CANCER, 87(11), 2000, pp. 777-791
Soluble CD16 in plasma cell dyscrasias
Authors: Mathiot, C Galon, J Tartour, E Teillaud, JL Facon, T Bataille, R Fridman, WH Sautes, C
Citation: C. Mathiot et al., Soluble CD16 in plasma cell dyscrasias, LEUK LYMPH, 32(5-6), 1999, pp. 467-474
Restoration of transcriptional activity of p53 mutants in human tumour cells by intracellular expression of anti-p53 single chain Fv fragments
Authors: de Fromentel, CC Gruel, N Venot, C Debussche, L Conseiller, E Dureuil, C Teillaud, JL Tocque, B Bracco, L
Citation: Cc. De Fromentel et al., Restoration of transcriptional activity of p53 mutants in human tumour cells by intracellular expression of anti-p53 single chain Fv fragments, ONCOGENE, 18(2), 1999, pp. 551-557
A tumor specific single chain antibody dependent gene expression system
Authors: Mary, MN Venot, C de Fromentel, CC Debussche, L Conseiller, E Cochet, O Gruel, N Teillaud, JL Schweighoffer, F Tocque, B Bracco, L
Citation: Mn. Mary et al., A tumor specific single chain antibody dependent gene expression system, ONCOGENE, 18(2), 1999, pp. 559-564
Selective PCR amplification of functional immunoglobulin light chain from hybridoma containing the aberrant MOPC 21-derived V kappa by PNA-mediated PCR clamping
Authors: Cochet, O Martin, E Fridman, WH Teillaud, JL
Citation: O. Cochet et al., Selective PCR amplification of functional immunoglobulin light chain from hybridoma containing the aberrant MOPC 21-derived V kappa by PNA-mediated PCR clamping, BIOTECHNIQU, 26(5), 1999, pp. 818
A therapeutic Trojan horse: intracellular antibodies.
Authors: Teillaud, JL
Citation: Jl. Teillaud, A therapeutic Trojan horse: intracellular antibodies., PATH BIOL, 47(8), 1999, pp. 771-775
Ras and p53 intracellular targeting with recombinant single-chain Fv (scFv) fragments: A novel approach for cancer therapy?
Authors: Cochet, O Gruel, N Fridman, WH Teillaud, JL
Citation: O. Cochet et al., Ras and p53 intracellular targeting with recombinant single-chain Fv (scFv) fragments: A novel approach for cancer therapy?, CANCER DET, 23(6), 1999, pp. 506-510
Generation of phagocytic MAK and MAC-DC for therapeutic use: Characterization and in vitro functional properties
Authors: Boyer, A Andreu, G Romet-Lemonne, JL Fridman, WH Teillaud, JL
Citation: A. Boyer et al., Generation of phagocytic MAK and MAC-DC for therapeutic use: Characterization and in vitro functional properties, EXP HEMATOL, 27(4), 1999, pp. 751-761
Vav and SLP-76 recruitment by cross-linking of Fc gamma RIIa1 in promyelocytic HL-60 cells
Authors: Rouard, H Tamasdan, S Fridman, WH Teillaud, JL
Citation: H. Rouard et al., Vav and SLP-76 recruitment by cross-linking of Fc gamma RIIa1 in promyelocytic HL-60 cells, IMMUNOL LET, 68(2-3), 1999, pp. 347-353
Immunoglobulin variable regions usage by B-lymphocytes infiltrating a human breast medullary carcinoma
Authors: Kotlan, B Gruel, N Zafrani, B Furedi, G Foldi, J Petranyi, GG Fridman, WH Teillaud, JL
Citation: B. Kotlan et al., Immunoglobulin variable regions usage by B-lymphocytes infiltrating a human breast medullary carcinoma, IMMUNOL LET, 65(3), 1999, pp. 143-151
Intracellular expression and functional properties of an anti-p21(Ras) scFv derived from a rat hybridoma containing specific lambda and irrelevant kappa light chains
Authors: Cochet, O Kenigsberg, M Delumeau, I Duchesne, M Schweighoffer, F Tocque, B Teillaud, JL
Citation: O. Cochet et al., Intracellular expression and functional properties of an anti-p21(Ras) scFv derived from a rat hybridoma containing specific lambda and irrelevant kappa light chains, MOL IMMUNOL, 35(17), 1998, pp. 1097-1110
Tumor immunology: a new look
Authors: Fridman, WH Pages, F Michon, J Teillaud, JL Tartour, E
Citation: Wh. Fridman et al., Tumor immunology: a new look, RESEARCH IN, 1998, pp. 3-22
Risultati: 1-17 |